St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System

St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release.

Advertisement

 

The Epiducer system allows placement of as many as three neurostimulation leads through a single entry point.

 

The system also allows introduction of St. Jude Medical S-Series paddle leads through a percutaneous entry.

 

Read the St. Jude Medical release on approval of Epiducer.

 

Related Articles on Neurostimulation Therapy:

5 Keys for Pain Management Physicians to Ensure Success in 2011

Neurostimulation System Shows Positive Findings in Treating Cluster Headache

Study: Peripheral Nerve Stimulation Reduces Migraines

 

 

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.